Related Experiment Videos

Follow up of patients with postpartum thyroiditis: a population-based study

Farzaneh Sarvghadi1, Mehdi Hedayati, Yadollah Mehrabi

  • 1Endocrine Research Center, Shahid Beheshti University of Medical Sciences, Tehran, I.R. Iran.

Endocrine
|October 19, 2005
PubMed

In this survey we studied the prevalence of permanent hypothyroidism and prognostic factors for its occurrence 3-5 yr after postpartum thyroiditis (PPT); 54 of 120 women with PPT and 50 of 920 healthy women from among 1,040 women followed 4-5 yr earlier for PPT were recalled. Demographic information, signs, and symptoms of thyroid disorders and results of physical exams were documented. Serum T3, T4, RT3U, TSH, and anti-thyroperoxidase (anti-TPO ab) and anti-thyro-gluboline (anti-Tg ab) antibodies were measured. Twenty-two percent of the cases and four percent of the control group had permanent hypothyroidism, p<0.01. Based on the TSH level we divided the case group into two subgroups: PPT-Hypothyroidism (PPT-Hypo) and PPT-Eutyhroidism (PPT-EU); PPT-Hypo had greater titer of anti-TPO ab than PPT-Eu (437+/-283 vs 126+/-221 IU/mL, p<0.001). Comparison of mean peak serum TSH level and anti-TPO ab during the postpartum thyroiditis phase between PPT-Hypo and PPT-Eu in the case group was significant (56+/- 24 vs 23+/- 28 mU/L, p<0.001, and 1960+/-1270 vs 640+/-959 IU/L, p<0.001, respectively). Results of this survey show a high prevalence of permanent hypothyroidism following PPT in Tehran. High titers of anti-TPOAb and TSH levels at postpartum period are prognostic factors for occurrence of permanent hypothyroidism.

Related Concept Videos

Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...